Tyrosine-KinaseInhibitorDisease-FreeSurvivalRateAlopeciaBRCAGeneMastectomyLymphoscintigraphyMRICyclophosphamideBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MultifocalTumorsLymphNodeStatusPalbociclibBevacizumabAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenNodeNegativeDiabeticMastopathyAntibodyTherapySERMTamoxifenCytostaticNodePositiveCDK4/6InhibitorsCapecitabineDimplingLiquidBiopsyChemotherapyMastitisHormoneReceptorStatusBOCACMFChemotherapyStagingProgestinmTORInhibitorsMastalgiaIntraductalPapillomaIn-situCarcinomaHER-2TriplePositiveBreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.NeoadjuvantTherapyMegestrolAcetateGenomicTestingPalpationEndometrialCancerDoseDenseTherapyMetastaticBreastCancerAbsoluteRiskCo-survivorFibroadenomaChemopreventionPagetDiseaseHerceptinBreastCancerExcisionalBiopsyEstrogenACChemotherapyApoptosisER+Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltAngiogenesisAdvocacyAromataseInhibitorsTripleNegativeBreastCancerGermlineMutationRADPaclitaxelKappaEpsilonNeoplasmPrecisionMedicineDefinitiveSurgeryGeneMutationAnastrozoleBiopsyOligometastasesFlowCytometryCalcificationsFamilyHistoryLCISAdenocarcinomaCAMECOGScoreHormoneReplacementTherapyBI-RADSMethotrexateGuaranteedRenewableInsuranceEvidencesuggests thatphysical activitymay reduce therisk of breastcancersDoxorubicinAyurvedaAxillarySamplingInvasiveBreastCancerDocetaxelSclerosingAdenosisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCytotoxicER-Immunotherapy1 in 8womenEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMultimodalityTherapyPARPInhibitorsPI3KinaseInhibitorsLumpMastodynialatissimusflap5-FluorouracilMolecularBreastImagingCystLumpectomySelf-examinationBilateralProphylacticMastectomyWomen ages40+ shouldhave a clinicalbreast examat least yearlyPhyllodesTumorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BenignPhyllodesTumorMetastasisCheckpointInhibitorBrachytherapyOvarianSuppressionAdjuvantTherapyMorpheaRelapseRadiotherapyLapatinibBreastTomosynthesisTumorGradeGeneticPredispositionAntiemeticOophorectomyFISHCachexiaGailModelKi-67RateDown-StagingRaloxifenePathologicResponseGeneticCounselingEstradiolEGFR(epidermalgrowth factorreceptor)Tyrosine-KinaseInhibitorDisease-FreeSurvivalRateAlopeciaBRCAGeneMastectomyLymphoscintigraphyMRICyclophosphamideBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MultifocalTumorsLymphNodeStatusPalbociclibBevacizumabAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenNodeNegativeDiabeticMastopathyAntibodyTherapySERMTamoxifenCytostaticNodePositiveCDK4/6InhibitorsCapecitabineDimplingLiquidBiopsyChemotherapyMastitisHormoneReceptorStatusBOCACMFChemotherapyStagingProgestinmTORInhibitorsMastalgiaIntraductalPapillomaIn-situCarcinomaHER-2TriplePositiveBreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.NeoadjuvantTherapyMegestrolAcetateGenomicTestingPalpationEndometrialCancerDoseDenseTherapyMetastaticBreastCancerAbsoluteRiskCo-survivorFibroadenomaChemopreventionPagetDiseaseHerceptinBreastCancerExcisionalBiopsyEstrogenACChemotherapyApoptosisER+Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltAngiogenesisAdvocacyAromataseInhibitorsTripleNegativeBreastCancerGermlineMutationRADPaclitaxelKappaEpsilonNeoplasmPrecisionMedicineDefinitiveSurgeryGeneMutationAnastrozoleBiopsyOligometastasesFlowCytometryCalcificationsFamilyHistoryLCISAdenocarcinomaCAMECOGScoreHormoneReplacementTherapyBI-RADSMethotrexateGuaranteedRenewableInsuranceEvidencesuggests thatphysical activitymay reduce therisk of breastcancersDoxorubicinAyurvedaAxillarySamplingInvasiveBreastCancerDocetaxelSclerosingAdenosisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCytotoxicER-Immunotherapy1 in 8womenEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMultimodalityTherapyPARPInhibitorsPI3KinaseInhibitorsLumpMastodynialatissimusflap5-FluorouracilMolecularBreastImagingCystLumpectomySelf-examinationBilateralProphylacticMastectomyWomen ages40+ shouldhave a clinicalbreast examat least yearlyPhyllodesTumorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BenignPhyllodesTumorMetastasisCheckpointInhibitorBrachytherapyOvarianSuppressionAdjuvantTherapyMorpheaRelapseRadiotherapyLapatinibBreastTomosynthesisTumorGradeGeneticPredispositionAntiemeticOophorectomyFISHCachexiaGailModelKi-67RateDown-StagingRaloxifenePathologicResponseGeneticCounselingEstradiolEGFR(epidermalgrowth factorreceptor)

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Tyrosine-Kinase Inhibitor
  2. Disease-Free Survival Rate
  3. Alopecia
  4. BRCA Gene
  5. Mastectomy
  6. Lymphoscintigraphy
  7. MRI
  8. Cyclophosphamide
  9. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  10. Multifocal Tumors
  11. Lymph Node Status
  12. Palbociclib
  13. Bevacizumab
  14. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  15. Node Negative
  16. Diabetic Mastopathy
  17. Antibody Therapy
  18. SERM
  19. Tamoxifen
  20. Cytostatic
  21. Node Positive
  22. CDK4/6 Inhibitors
  23. Capecitabine
  24. Dimpling
  25. Liquid Biopsy
  26. Chemotherapy
  27. Mastitis
  28. Hormone Receptor Status
  29. BOCA
  30. CMF Chemotherapy
  31. Staging
  32. Progestin
  33. mTOR Inhibitors
  34. Mastalgia
  35. Intraductal Papilloma
  36. In-situ Carcinoma
  37. HER-2
  38. Triple Positive Breast Cancer
  39. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  40. Neoadjuvant Therapy
  41. Megestrol Acetate
  42. Genomic Testing
  43. Palpation
  44. Endometrial Cancer
  45. Dose Dense Therapy
  46. Metastatic Breast Cancer
  47. Absolute Risk
  48. Co-survivor
  49. Fibroadenoma
  50. Chemoprevention
  51. Paget Disease
  52. Herceptin
  53. Breast Cancer
  54. Excisional Biopsy
  55. Estrogen
  56. AC Chemotherapy
  57. Apoptosis
  58. ER+
  59. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  60. Angiogenesis
  61. Advocacy
  62. Aromatase Inhibitors
  63. Triple Negative Breast Cancer
  64. Germline Mutation
  65. RAD
  66. Paclitaxel
  67. Kappa Epsilon
  68. Neoplasm
  69. Precision Medicine
  70. Definitive Surgery
  71. Gene Mutation
  72. Anastrozole
  73. Biopsy
  74. Oligometastases
  75. Flow Cytometry
  76. Calcifications
  77. Family History
  78. LCIS
  79. Adenocarcinoma
  80. CAM
  81. ECOG Score
  82. Hormone Replacement Therapy
  83. BI-RADS
  84. Methotrexate
  85. Guaranteed Renewable Insurance
  86. Evidence suggests that physical activity may reduce the risk of breast cancers
  87. Doxorubicin
  88. Ayurveda
  89. Axillary Sampling
  90. Invasive Breast Cancer
  91. Docetaxel
  92. Sclerosing Adenosis
  93. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  94. Cytotoxic
  95. ER-
  96. Immunotherapy
  97. 1 in 8 women
  98. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  99. Multimodality Therapy
  100. PARP Inhibitors
  101. PI3 Kinase Inhibitors
  102. Lump
  103. Mastodynia
  104. latissimus flap
  105. 5-Fluorouracil
  106. Molecular Breast Imaging
  107. Cyst
  108. Lumpectomy
  109. Self-examination
  110. Bilateral Prophylactic Mastectomy
  111. Women ages 40+ should have a clinical breast exam at least yearly
  112. Phyllodes Tumor
  113. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  114. Benign Phyllodes Tumor
  115. Metastasis
  116. Checkpoint Inhibitor
  117. Brachytherapy
  118. Ovarian Suppression
  119. Adjuvant Therapy
  120. Morphea
  121. Relapse
  122. Radiotherapy
  123. Lapatinib
  124. Breast Tomosynthesis
  125. Tumor Grade
  126. Genetic Predisposition
  127. Antiemetic
  128. Oophorectomy
  129. FISH
  130. Cachexia
  131. Gail Model
  132. Ki-67 Rate
  133. Down-Staging
  134. Raloxifene
  135. Pathologic Response
  136. Genetic Counseling
  137. Estradiol
  138. EGFR (epidermal growth factor receptor)